Aurra | Health News Aggregator

US-based Osiris Therapeutics has become the world's first company to receive regulatory approval to market a stem cell drug.

US biotechnology company Human Genome Sciences (HGS) has adopted a stockholder rights plan, or poison pill, after rejecting GlaxoSmithKline's (GSK's) bid to take over the company for $2.6bn.

Partec has been setting standards and pioneering the development of commercially available systems for cell and particle analysis for more than 50 years.

UK-based stem cell researcher ReNeuron has signed a cell manufacturing contract with Angel Biotechnology Holdings, which will provide materials for the remaining part of an early-stage clinical trial of ReN001 therapy to treat disabled stroke patient…

GlaxoSmithKline has increased its share in biopharmaceutical company Theravance, the firm's development partner of Relovair, a once-daily treatment for asthma and chronic obstructive pulmonary disease (COPD).

The development of drug delivery services that are more sensitive to the user is an important aspect of patient adherence. Dr Rolf Eilers, managing director of Balda Medical, discusses the importance of a tailored, user-focused approach to raising us…

From advances in robotic research to new cures for addictions and life-threatening diseases, drug developers are opening up new frontiers.

This paper addresses the importance of process protection in cleanrooms via the appropriate cleanroom suit.

The National Institute for Health and Clinical Excellence (NICE) has once again refused to recommend Sanofi's Jevtana (cabazitaxel), used to treat advanced prostate cancer.

What was once a laborious process is getting easier, thanks to modern sensors and calibration processes.

Benchmark Products once again received a great response from the attendees at the 2012 Interphex exhibition at the Jacobs Javits Center in New York City, in May. It was Benchmark's sixth consecutive successful year exhibiting at the East Coast event.

Even if risk is one of the most important words in the arena of the life sciences industry, it appears that it is not systematically taken into account as it should be.

A UK health watchdog has recommended the use of Janssen Pharmaceuticals' Zytiga (abiraterone) for the treatment of prostate cancer, after previously rejecting the drug.

ODVA has announced that Endress+Hauser, one of the world's leading suppliers of measurement, automation equipment and solutions for the process industries, will become a principal member, joining leading suppliers Bosch Rexroth, Cisco Systems, Rockwe…

Benchmark Products, a designer and distributor of cleanroom products, has released a free white paper on the evolution of sterile cleanroom gowning in minimising contamination risks.

People with multiple sclerosis (MS) could benefit from cannabis use to ease muscle spasticity, according to a new study.

GlaxoSmithKline (GSK) has entered into a take-over agreement to fully acquire Cellzome, a manufacturer of proteomics technologies, for £61m in cash.

Unpublished clinical trial data is a persistent problem which stems from the pursuit of safe, evidence-based medicine. Chris Lo investigates the dangers of missing trial data and asks how a more transparent system can be achieved in the future.

Aptalis Pharmaceutical Technologies has released two new free-to-download white papers on Pharmaceutical Technology.

In 2011, Axcan and Eurand joined forces to create Aptalis, an international speciality pharmaceutical company focused on cystic fibrosis and gastroenterology. In this Scrip100.com article John Fraher talks to Mike Ward about the direction of the newl…